VRTX
VERTEX PHARMACEUTICALS INC / MA
Key Financials
Net Income
$4.0B
↑ 838.1%
Revenue
$12.0B
↑ 8.9%
EPS (Diluted)
$15.32
↑ 836.5%
Operating Income
$4.2B
↑ 1891.9%
Total Assets
$25.6B
↑ 13.8%
Long-term Debt
$105.0M
N/A
Shareholders' Equity
$18.7B
↑ 13.7%
Cash & Equivalents
$5.1B
↑ 11.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VRTX |
| Company Name | VERTEX PHARMACEUTICALS INC / MA |
| CIK | 875320 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | MA |
| Phone | 6173416393 |